South Rampart Pharma Receives $1.9 Million NIH Fast-Track STTR Commercialization Grant to Advance its New Class of Non-Opioid Pain ...
NEW ORLEANS, Sept. 29, 2020 (GLOBE NEWSWIRE) -- South Rampart Pharma, a company committed to improving the lives of people suffering from pain by developing a new class of non-opioid pain medicines, has been awarded a $1.9 million Small Business Technology …